Markus Goebel started his career in the healthcare industry in 1990. An MD by training and certified, amongst others, in hematology/oncology he worked for Farmitalia Germany and later held several global positions in R&D, Marketing and Strategy at Roche headquarters to include a worldwide alliance with Amgen. He joined Novartis in 2000 and first worked as Global Head Nervous System BD&L Pharma and later as Global Head Pharma Corporate M&A. In 2004, he joined the Novartis Venture Fund (NVF) as a managing director in the US, moving back to Europe in 2009. He was appointed to be NVF Company Manager US in 2017. Previously, he received an MD and a PhD from the Ludwig Maximilian’s University in Munich and an MBA from Henley Management College. Dr. Goebel serves on the boards of several Novartis Venture Fund portfolio companies.